2018
DOI: 10.15406/ogij.2018.09.00391
|View full text |Cite
|
Sign up to set email alerts
|

Evolution of magnesium sulphate for eclampsia

Abstract: Eclampsia with its precursor preeclampsia is a condition that is rapidly taking the fore front in many countries as the leading cause of adverse maternal outcome, because of gains accruing from ability to curb, the better-understood obstetric haemorrhage. The exact mechanism by which preeclampsia leads to eclampsia remains unclear resulting in difficulty in prediction of individuals with preeclampsia who would develop eclampsia. Magnesium sulphate has been a recognised remedy since the early twentieth century,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 20 publications
0
2
0
Order By: Relevance
“…The results of this retrospective analysis of magnesium levels in a population of patients with SAH carries several implications regarding the monitoring and the prospect of identifying vasospasm. Although prior studies have mixed results in the effectiveness of magnesium as a treatment for vasospasm [5][6][7], a temporal association used to predict vasospasm is revealed by our results. While patients who did not experience clinical vasospasm showed no relationship when magnesium levels trended downwards, these results demonstrate that patients who do experience vasospasm had a significant moderate relationship in decreasing magnesium levels compared with periods of active vasospasm.…”
Section: Discussionmentioning
confidence: 55%
See 1 more Smart Citation
“…The results of this retrospective analysis of magnesium levels in a population of patients with SAH carries several implications regarding the monitoring and the prospect of identifying vasospasm. Although prior studies have mixed results in the effectiveness of magnesium as a treatment for vasospasm [5][6][7], a temporal association used to predict vasospasm is revealed by our results. While patients who did not experience clinical vasospasm showed no relationship when magnesium levels trended downwards, these results demonstrate that patients who do experience vasospasm had a significant moderate relationship in decreasing magnesium levels compared with periods of active vasospasm.…”
Section: Discussionmentioning
confidence: 55%
“…The timing of which phenomenon occurs first has not been established. The body, in response to vasospasm, may be consuming high levels of magnesium for its vasodilatory effect, which could lead to low serum levels of magnesium [ 7 ]. However, it is possible that magnesium levels are low due to a different cause in SAH patients.…”
Section: Introductionmentioning
confidence: 99%